Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Colon Targeting Drug Delivery Market Growth Performance Trended Historically, And What Lies Ahead?
Recent years have witnessed robust expansion in the colon-targeted drug delivery market. The market, valued at $1.39 billion in 2024, is expected to reach $1.5 billion in 2025, marking a compound annual growth rate (CAGR) of 7.5%. Key factors driving growth during the historical period include the escalating incidence of colorectal diseases, a heightened emphasis on locale-specific drug delivery, the imperative for enhanced patient compliance, along with the advent of biologics and peptides.
The market for colon targeting drug delivery is predicted to experience significant expansion in the upcoming years. The market is projected to reach $2.03 billion by 2029, with a compound annual growth rate (CAGR) of 7.9%. This growth during the predicted period can be ascribed to various factors such as the emergence of stimuli-responsive and nanotechnology-based delivery systems, the growth of contract research and manufacturing services, regulatory bodies providing incentives and expedited approval pathways, and the targeted delivery of biologics and biosimilars. The forecast period also anticipates trends like advancements in pH-responsive solutions, the incorporation of personalized medicine, the application of artificial intelligence and digital tools in formulation design, and a heightened emphasis on oral colon delivery.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24194&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theColon Targeting Drug Delivery Market?
The increase in gastrointestinal diseases is anticipated to drive the colon targeting drug delivery market’s expansion in the future. Gastrointestinal diseases include conditions impacting the digestion process, such as disorders of the stomach, intestines, and related organs. Unhealthy food habits, including high consumption of processed foods and inadequate fiber intake, are causing these diseases to rise as they negatively impact gut health and digestion. The application of colon targeting drug delivery in treating these diseases helps ensure accurate drug release at the inflammation or infection site, leading to improved therapeutic efficacy and lesser systemic side effects. For instance, Crohn’s and Colitis Canada, a nonprofit organization, reported in June 2023 that the number of people suffering from inflammatory bowel disease is supposed to rise from 322,600 in 2023 (amounting to 0.8% of the population) to 470,000 by 2035 (which is 1.1% of the population). Therefore, the growth of the colon targeting drug delivery market is fuelled by the rising prevalence of gastrointestinal diseases.
Which Segments in the Colon Targeting Drug Delivery Offer the Most Growth?
The colon targeting drug delivery market covered in this report is segmented –
1) By Dosage Form: Tablets, Capsules, Microspheres, Nanoparticles, Other Dosage Form
2) By Technology: pH-Sensitive Systems, Time-Dependent Systems, Microbially Triggered Systems, Pressure-Controlled Systems, Other Technologies
3) By Application: Inflammatory Bowel Disease, Colorectal Cancer, Infectious Diseases, Other Application
4) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Tablets: Extended-Release Tablets, Enteric-Coated Tablets, Osmotic Pump Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gelatin Capsules, Enteric-Coated Capsules
3) By Microspheres: Polymeric Microspheres, Biodegradable Microspheres, Non-biodegradable Microspheres
4) By Nanoparticles: Polymeric Nanoparticles, Solid Lipid Nanoparticles, Dendrimers, Lipid-Polymer Hybrid Nanoparticles
4) By Other Dosage Form: Films, Injections, Hydrogels, Suppositories
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24194&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theColon Targeting Drug Delivery Market?# Market?
North America was the largest region in the colon targeting drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colon targeting drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Colon Targeting Drug Delivery Industry?
Leading businesses in the colon targeting drug delivery market are concentrating their efforts on creating novel drug delivery systems, including functional oral dosage forms. These advancements are aimed at enhancing targeted drug discharge, increasing therapeutic efficacy, and mitigating adverse effects. The said functional oral dosage forms, utilized in colon-targeted drug delivery, guarantee the shielded passage of active pharmaceutical constituents, preventing their decay in the upper gastrointestinal tract and assuring their regulated discharge in the colon. As an example, in September 2024, German specialty chemical corporation, Evonik Industries AG introduced EUDRACAP Functional – a ready-to-fill capsule technology that targets the colon for oral drug conveyance. This technologically advanced solution ensures precise drug release by harnessing pH-sensitive polymers, which dissolve exclusively at certain intestinal pH levels, guaranteeing the API’s safe arrival to the colon. EUDRACAP Functional is instrumental in making possible the oral conveyance of complex APIs like peptides and probiotics, and in supporting the formulation of more patient-friendly treatments. This opens up new venues for the effective treatment of chronic gastrointestinal ailments with enhanced precision and minimized systemic exposure.
View the full report here:
https://www.thebusinessresearchcompany.com/report/colon-targeting-drug-delivery-global-market-report
What Are the Key Elements That Define the Colon Targeting Drug Delivery Market?
Colon targeting drug delivery refers to a specialized drug delivery system designed to release therapeutic agents specifically in the colon, enhancing treatment efficacy for local diseases such as inflammatory bowel disease and colorectal cancer, while minimizing systemic side effects and improving patient compliance.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24194
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model